Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Return on Sales (2020 - 2025)

BioAtla (BCAB) has 3 years of Return on Sales data on record, last reported at 406.62% in Q1 2022.

  • For Q1 2022, Return on Sales fell 26664.0% year-over-year to 406.62%; the TTM value through Mar 2022 reached 406.62%, down 26664.0%, while the annual FY2024 figure was 6.42%, N/A changed from the prior year.
  • Return on Sales reached 406.62% in Q1 2022 per BCAB's latest filing, down from 384.38% in the prior quarter.
  • Across five years, Return on Sales topped out at 12.4% in Q1 2020 and bottomed at 406.62% in Q1 2022.
  • Average Return on Sales over 3 years is 174.25%, with a median of 121.52% recorded in 2021.
  • The widest YoY moves for Return on Sales: up -9774bps in 2021, down -31446bps in 2021.
  • A 3-year view of Return on Sales shows it stood at 69.93% in 2020, then plummeted by -450bps to 384.38% in 2021, then dropped by -6bps to 406.62% in 2022.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 406.62% in Q1 2022, 384.38% in Q4 2021, and 356.38% in Q3 2021.